Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity

Annals of Surgery

Volumn 266, Issue 4, 2017, Pages 650-657

  Aminian, Ali ^a   Brethauer, Stacy A ^a   Andalib, Amin ^b   Nowacki, Amy S ^a   Jimenez, Amanda ^c   Corcelles, Ricard ^c   Hanipah, Zubaidah Nor ^a,d   Punchai, Suriya ^a,e   Bhatt, Deepak L ^f   Kashyap, Sangeeta R ^a   Burguera, Bartolome ^a   Lacy, Antonio M ^c   Vidal, Josep ^c,g   Schauer, Philip R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^e KHON KAEN UNIVERSITY   (Thailand)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

bariatric surgery; diabetes; gastric bypass; glycemic; individualized; metabolic surgery; personalized; remission; sleeve gastrectomy

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN;

ADULT; BARIATRIC SURGERY; CLINICAL FEATURE; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INDIVIDUALIZED METABOLIC SURGERY SCORE; INTERMEDIATE RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; ROUX-EN-Y GASTRIC BYPASS; SCORING SYSTEM; SLEEVE GASTRECTOMY; SURGICAL TECHNIQUE; COMPLICATION; DIABETES MELLITUS, TYPE 2; GASTRECTOMY; GASTRIC BYPASS SURGERY; OBESITY, MORBID; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 85025829339     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000002407     Document Type: Conference Paper

References (36)

1. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386:964-973.
2. Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015;150:931-940.
3. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309:2240-2249.
4. Cummings DE, Arterburn DE,Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59:945-953.
5. Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Diabetes Care. 2016;39:861-877.
6. Khorgami Z, Shoar S, Andalib A, et al. Trends in utilization of bariatric surgery, 2010-2014: sleeve gastrectomy dominates. Surg Obes Relat Dis. 2017;13:774-778.
7. Helmio M, Victorzon M, Ovaska J, et al. Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: A prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up. Scand J Surg. 2014;103:175-181.
8. Peterli R,Wolnerhanssen BK, Vetter D, et al. Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity: 3-year outcomes of the prospective randomized Swiss Multicenter Bypass Or Sleeve Study (SMBOSS). Ann Surg. 2017;265:466-473.
9. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med. 2014; 370:2002-2013.
10. Aminian A, Brethauer SA, Andalib A, et al. Can sleeve gastrectomy ''cure'' diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes. Ann Surg. 2016;264:674-681.
11. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013;23:93-102.
12. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes: 5-year outcomes. N Engl J Med. 2017;376: 641-651.
13. Brethauer SA, Aminian A, Romero-Talamas H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258:628-636 [discussion 636-637].
14. Jimenez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256:1023-1029.
15. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133-2135.
16. Zhang R, Borisenko O, Telegina I, et al. Systematic review of risk prediction models for diabetes after bariatric surgery. Br J Surg. 2016;103:1420-1427.
17. Aminian A, Brethauer SA, Sharafkhah M, et al. Development of a sleeve gastrectomy risk calculator. Surg Obes Relat Dis. 2015;11:758-764.
18. Aminian A, Andalib A, Khorgami Z, et al. A nationwide safety analysis of bariatric surgery in nonseverely obese patients with type 2 diabetes. Surg Obes Relat Dis. 2016;12:1163-1170.
19. Andalib A, Aminian A, Khorgami Z, et al. Safety analysis of primary bariatric surgery in patients on chronic dialysis. Surg Endosc. 2016;30: 2583-2591.
20. Andalib A, Aminian A, Khorgami Z, et al. Early postoperative outcomes of primary bariatric surgery in patients on chronic steroid or immunosuppressive therapy. Obes Surg. 2016;26:1479-1486.
21. Nelson LG, Gonzalez R, Haines K, et al. Amelioration of gastroesophageal reflux symptoms following Roux-en-Y gastric bypass for clinically significant obesity. Am Surg. 2005;71:950-953 [discussion 953-954].
22. Houghton SG, Romero Y, Sarr MG. Effect of Roux-en-Y gastric bypass in obese patients with Barrett's esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis. 2008;4:1-4 [discussion 4-5].
23. Nadaleto BF, Herbella FA, Patti MG. Gastroesophageal reflux disease in the obese: pathophysiology and treatment. Surgery. 2016;159:475-486.
24. Aminian A, Andalib A, Ver MR, et al. Outcomes of bariatric surgery in patients with inflammatory bowel disease. Obes Surg. 2016;26:1186-1190.
25. Shoar S, Shahabuddin Hoseini S, Naderan M, et al. Bariatric surgery in morbidly obese patients with inflammatory bowel disease: a systematic review. Surg Obes Relat Dis. 2017;13:652-659.
26. Rogers CC, Alloway RR, Alexander JW, et al. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in endstage renal disease and transplant patients: a pilot study. Clin Transplant. 2008;22:281-291.
27. Still CD,Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol. 2014;2:38-45.
28. Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013;9:379-384.
29. LeeWJ, Almulaifi A, Tsou JJ, et al. Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus: predicting the success by ABCD score. Surg Obes Relat Dis. 2015;11:991-996.
30. Kirwan JP, Aminian A, Kashyap SR, et al. Bariatric surgery in obese patients with type 1 diabetes. Diabetes Care. 2016;39:941-948.
31. Batterham RL, Cummings DE. Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care. 2016;39:893-901.
32. Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254:410-420.
33. Ignat M, Vix M, Imad I, et al. Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg. 2017;104:248-256.
34. Berger ER, Clements RH, Morton JM, et al. The impact of different surgical techniques on outcomes in laparoscopic sleeve gastrectomies: the first report from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP). Ann Surg. 2016;264:464-473.
35. Aminian A, Brethauer SA, Daigle CR, et al. Outcomes of bariatric surgery in type 2 diabetic patients with diminished pancreatic secretory reserve. Acta Diabetol. 2014;51:1077-1079.
36. Souteiro P, Belo S, Neves JS, et al. Preoperative beta cell function is predictive of diabetes remission after bariatric surgery. Obes Surg. 2017;27:288-294.